Concepedia

Author

Liliana Grinfeld

Hospital Italiano de Buenos Aires

Also Known As

Assen R. Goudev, Florencia Rolandi, L Grinfeld, L. Grinfeld, Liliana Grinfeld, Liliana R Grinfeld, Liliana R. Grinfeld, Liliana Rosa Grinfeld, Werdan, Karl

102

Publications

5.1K

Citations

28

H-Index

41

Concepts

All Affiliations

Hospital Italiano de Buenos AiresNorthwestern UniversityAssociazione Nazionale Medici Cardiologi OspedalieriTufts Medical CenterUniversidad de Buenos Aires
LG

About

Liliana Grinfeld is an author at Hospital Italiano de Buenos Aires specializing in cardiology, medicine, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

23

2.9K

2

Emergency Medicine

11

11

601

3

Public Health

6

6

575

4

Epidemiology

1

1

371

5

Gender Studies

1

1

27

Liliana Grinfeld

×

39

Publications

4.9K

Citations

27

H-Index

YearCitations

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

John R. Teerlink, Gad Cotter, Beth A. Davison,

The Lancet

2012

896

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

Stephen G. Ellis, Michał Tendera, Mark de Belder,

New England Journal of Medicine

2008

692

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial

Andrew P. Ambrosy, Peter S. Pang, Sadiya S. Khan,

European Heart Journal

2013

553

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program

Marco Metra, Gad Cotter, Beth A. Davison,

Journal of the American College of Cardiology

2012

423

Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results

Alfredo E. Rodríguez, Víctor Bernardi, José Navia,

Journal of the American College of Cardiology

2001

371

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure

John E. Blair, Faı̈ez Zannad, Marvin A. Konstam,

Journal of the American College of Cardiology

2008

174

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

Mihai Gheorghiade, Cesare Orlandi, John C. Burnett,

Journal of Cardiac Failure

2005

171

Clinical Course of Patients With Hyponatremia and Decompensated Systolic Heart Failure and the Effect of Vasopressin Receptor Antagonism With Tolvaptan

Paul J. Hauptman, John C. Burnett, Mihai Gheorghiade,

Journal of Cardiac Failure

2013

153

Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial

Jennifer Yu, Roxana Mehran, Liliana Grinfeld,

Catheterization and Cardiovascular Interventions

2014

139

A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial

Mihai Gheorghiade, Peter S. Pang, Andrew P. Ambrosy,

Heart Failure Reviews

2011

120

Page 1